Author:
Morya Arvind Kumar,Ramesh Prasanna Venkatesh,Nishant Prateek,Kaur Kirandeep,Gurnani Bharat,Heda Aarti,Salodia Sarika
Abstract
Diabetes mellitus (DM) is a chronic metabolic non-communicable disease with the ability to cause serious microvascular and macrovascular complications throughout the body, including in the eye. Diabetic retinopathy (DR), present in one-third of patients with diabetes, is a vision-threatening complication caused by uncontrolled diabetes, which greatly affects the retinal blood vessels and the light-sensitive inner retina, eventually leading to blindness. Several epidemiological studies elucidate that DR can vary by age of onset, duration, types of diabetes, and ethnicity. Recent studies show that the pathogenesis of diabetic retinopathy has spread its roots beyond merely being the result of hyperglycemia. The complexity of its etiopathology and diagnosis makes therapeutic intervention challenging. This review throws light on the pathological processes behind DR, the cascade of events that follow it, as well as the available and emerging treatment options.
Publisher
Baishideng Publishing Group Inc.
Reference106 articles.
1. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
2. Centers for Disease Control and Prevention; National Center for Chronic Disease Prevention and Health Promotion. National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. (2017). (accessed May 1, 2018). Available from: www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf
3. International Diabetes Federation. IDF Diabetes Atlas, seventh edition 2015. [online], (2015). Available from: https://diabetesatlas.org/idfawp/resource-files/2012/07/IDF_diabetes_atlas_seventh_edition_en.pdf
4. Neurodegeneration in diabetic retinopathy: does it really matter?
5. Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective